Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Molnupiravir

🥰Excellent
Catalog No. T60951Cas No. 2492423-29-5
Alias MK-4482, Lagevrio, EIDD-2801

Molnupiravir (EIDD-2801) is an isopropyl ester prodrug of the ribonucleoside analog EIDD-1931 with oral bioavailability. Molnupiravir can be used in the study of COVID-19, seasonal and pandemic influenza, and has broad-spectrum antiviral activity against multiple coronaviruses and influenza viruses, such as SARS-CoV-2, MERS-CoV, SARS-CoV.

Molnupiravir

Molnupiravir

🥰Excellent
Purity: 100%
Catalog No. T60951Alias MK-4482, Lagevrio, EIDD-2801Cas No. 2492423-29-5
Molnupiravir (EIDD-2801) is an isopropyl ester prodrug of the ribonucleoside analog EIDD-1931 with oral bioavailability. Molnupiravir can be used in the study of COVID-19, seasonal and pandemic influenza, and has broad-spectrum antiviral activity against multiple coronaviruses and influenza viruses, such as SARS-CoV-2, MERS-CoV, SARS-CoV.
Pack SizePriceAvailabilityQuantity
5 mg$34In Stock
10 mg$55In Stock
25 mg$72In Stock
50 mg$122In Stock
100 mg$197In Stock
200 mg$372In Stock
500 mg$788In Stock
1 g$1,080In Stock
1 mL x 10 mM (in DMSO)$61In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Molnupiravir"

Select Batch
Purity:100%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Molnupiravir (EIDD-2801) is an isopropyl ester prodrug of the ribonucleoside analog EIDD-1931 with oral bioavailability. Molnupiravir can be used in the study of COVID-19, seasonal and pandemic influenza, and has broad-spectrum antiviral activity against multiple coronaviruses and influenza viruses, such as SARS-CoV-2, MERS-CoV, SARS-CoV.
In vitro
METHODS: RD, Huh7, and Vero cells were treated with Molnupiravir (MK-4482) (EIDD-2801) (1, 10, 100 μM) for cytopathic effect (CPE) protection assay.
RESULTS EIDD-2801 showed stable CPE protection potential in a dose-dependent manner in multiple cell lines infected with EV-A71 virus; the value against EV-A71 virus was 70.12±4.40μM in RD cells; 88.52±3.18μM in Vero cells, and 35.64±0.47μM in Huh7 cells. [1]
In vivo
METHODS: Molnupiravir (MK-4482) (EIDD-2801) (50, 150, or 500 mg/kg, orally, every 12 hours) was used to prophylactically treat mice infected with SARS-CoV and observe its effects in mice.
RESULTS Molnupiravir has potent antiviral activity and is able to prevent SARS-CoV replication and disease. [1]
AliasMK-4482, Lagevrio, EIDD-2801
Chemical Properties
Molecular Weight329.31
FormulaC13H19N3O7
Cas No.2492423-29-5
SmilesCC(C)C(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cc\c(=N/O)[nH]c1=O
Storage & Solubility Information
Storagestore at low temperature | Shipping with blue ice.
Solubility Information
DMSO: 40 mg/mL (121.47 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.0367 mL15.1833 mL30.3665 mL151.8326 mL
5 mM0.6073 mL3.0367 mL6.0733 mL30.3665 mL
10 mM0.3037 mL1.5183 mL3.0367 mL15.1833 mL
20 mM0.1518 mL0.7592 mL1.5183 mL7.5916 mL
50 mM0.0607 mL0.3037 mL0.6073 mL3.0367 mL
100 mM0.0304 mL0.1518 mL0.3037 mL1.5183 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Molnupiravir | purchase Molnupiravir | Molnupiravir cost | order Molnupiravir | Molnupiravir chemical structure | Molnupiravir in vivo | Molnupiravir in vitro | Molnupiravir formula | Molnupiravir molecular weight